Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) EBIT Margin (2022 - 2025)

Envoy Medical's EBIT Margin history spans 4 years, with the latest figure at 8513.33% for Q4 2025.

  • Quarterly results put EBIT Margin at 8513.33% for Q4 2025, up 231762.0% from a year ago — trailing twelve months through Dec 2025 was 9240.66% (down 68200.0% YoY), and the annual figure for FY2025 was 9240.66%, down 68244.0%.
  • EBIT Margin for Q4 2025 was 8513.33% at Envoy Medical, up from 13590.48% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 3150.88% in Q3 2022 to a low of 14530.0% in Q4 2022.
  • The 4-year median for EBIT Margin is 7706.63% (2024), against an average of 8268.82%.
  • The sharpest move saw EBIT Margin soared 745316bps in 2023, then crashed -471190bps in 2025.
  • Year by year, EBIT Margin stood at 14530.0% in 2022, then soared by 51bps to 7076.84% in 2023, then plummeted by -53bps to 10830.95% in 2024, then rose by 21bps to 8513.33% in 2025.
  • According to Business Quant data, EBIT Margin over the past three periods came in at 8513.33%, 13590.48%, and 6500.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.